← back to search

He Chen

Nanchang University · CN
Area of research
Cancer Research · Molecular Biology
Research interest
Research interests include Cancer-related molecular mechanisms research, MicroRNA in disease regulation, Circular RNAs in diseases, and Hippo pathway signaling and YAP/TAZ.
h-index
22
citations
2,860
works
50
NIH funding
primary concept
email

Recent publications

Metformin and simvastatin synergistically suppress endothelin 1‐induced hypoxia and angiogenesis in multiple cancer types
Cancer Science 2022cited by 26position: middledoi
Growth arrest‐specific transcript 5 represses endometrial cancer development by promoting antitumor function of tumor‐associated macrophages
Cancer Science 2022cited by 24position: middledoi
Dependability of Automated Breast Ultrasound (ABUS) in Assessing Breast Imaging Reporting and Data System (BI-RADS) Category and Size of Malignant Breast Lesions Compared with Handheld Ultrasound (HHUS) and Mammography (MG)
International Journal of General Medicine 2021cited by 6position: firstdoi
MicroRNA-27a promotes tumorigenesis in tongue squamous cell carcinoma by enhancing proliferation, migration and suppressing apoptosis
European Archives of Oto-Rhino-Laryngology 2021cited by 2position: firstdoi
ELFN1-AS1 accelerates cell proliferation, invasion and migration via regulating miR-497-3p/CLDN4 axis in ovarian cancer
Bioengineered 2020cited by 43position: middledoi
ELFN1-AS1 accelerates cell proliferation, invasion and migration via regulating miR-497-3p/CLDN4 axis in ovarian cancer
Figshare 2020cited by 0position: middledoi
MicroRNA‐222‐3p participates in the development of oral squamous cell carcinoma by targeting CDKN1B
Journal of Oral Pathology and Medicine 2019cited by 10position: middledoi
Long noncoding RNA Hoxaas3 contributes to hypoxia-induced pulmonary artery smooth muscle cell proliferation
Cardiovascular Research 2018cited by 62position: middledoi
Increased levels of the long noncoding RNA, HOXA-AS3, promote proliferation of A549 cells
Cell Death and Disease 2018cited by 48position: middledoi
RETRACTED: MiR-101-3p inhibits the growth and metastasis of non-small cell lung cancer through blocking PI3K/AKT signal pathway by targeting MALAT-1
Biomedicine & Pharmacotherapy 2017cited by 100position: middledoi
Long non-coding RNA CCAT2 promotes epithelial-mesenchymal transition involving Wnt/β-catenin pathway in epithelial ovarian carcinoma cells
Oncology Letters 2017cited by 24position: middledoi
STAT3-dependent transactivation of miRNA genes following Toxoplasma gondii infection in macrophage
Parasites & Vectors 2013cited by 53position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Youkun Jie · Nanchang University2 papers (2020–2020)Daling Zhu · Ministry of Education of the People's Republic of China2 papers (2018–2018)Min Zhang · Nanchang University2 papers (2018–2018)Ying Liu · Shandong University2 papers (2018–2018)Yanping Chen · Guizhou University2 papers (2019–2021)Lixin Yan · Harbin Medical University2 papers (2018–2018)Wenfeng He · Guangzhou University of Chinese Medicine2 papers (2020–2020)Zhiying Yu · Nanjing Agricultural University1 papers (2022–2022)Jianghui Zhao · Hebei Medical University1 papers (2019–2019)Peiling Li · Guangzhou University of Chinese Medicine1 papers (2017–2017)Xuewen Tan · Ministry of Education of the People's Republic of China1 papers (2022–2022)Zhiming Dong · Hebei Medical University1 papers (2021–2021)Huan Yang · Institute of Infection and Immunity1 papers (2022–2022)Xiaodong Zheng · Medical College of Wisconsin1 papers (2018–2018)Yonghui Fu · Nanchang University1 papers (2020–2020)Hanliang Sun · Harbin Medical University1 papers (2018–2018)Jilong Shen · Nanjing University of Chinese Medicine1 papers (2013–2013)Kaicheng Yang · Hebei Medical University1 papers (2019–2019)Jianguang Zhao · Hebei Medical University1 papers (2019–2019) · 1 papers (2013–2013)